These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Clinical Outcome
18 results:

  • 1. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
    Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
    Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. stat3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
    Bitsch R; Kurzay A; Özbay Kurt F; De La Torre C; Lasser S; Lepper A; Siebenmorgen A; Müller V; Altevogt P; Utikal J; Umansky V
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35301236
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
    Del Bianco P; Pinton L; Magri S; Canè S; Masetto E; Basso D; Padovan M; Volpin F; d'Avella D; Lombardi G; Zagonel V; Bronte V; Della Puppa A; Mandruzzato S
    Front Immunol; 2021; 12():809826. PubMed ID: 35069595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
    Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
    Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
    Craveiro RB; Ehrhardt M; Velz J; Olschewski M; Goetz B; Pietsch T; Dilloo D
    Oncotarget; 2017 Jul; 8(29):46915-46927. PubMed ID: 28159923
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CD133
    Garg N; Bakhshinyan D; Venugopal C; Mahendram S; Rosa DA; Vijayakumar T; Manoranjan B; Hallett R; McFarlane N; Delaney KH; Kwiecien JM; Arpin CC; Lai PS; Gómez-Biagi RF; Ali AM; de Araujo ED; Ajani OA; Hassell JA; Gunning PT; Singh SK
    Oncogene; 2017 Feb; 36(5):606-617. PubMed ID: 27775079
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HDAC7 inhibition resets stat3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
    Peixoto P; Blomme A; Costanza B; Ronca R; Rezzola S; Palacios AP; Schoysman L; Boutry S; Goffart N; Peulen O; Maris P; Di Valentin E; Hennequière V; Bianchi E; Henry A; Meunier P; Rogister B; Muller RN; Delvenne P; Bellahcène A; Castronovo V; Turtoi A
    Oncogene; 2016 Aug; 35(34):4481-94. PubMed ID: 26853466
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
    Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
    Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.
    Khan FH; Pandian V; Ramraj S; Aravindan S; Herman TS; Aravindan N
    BMC Genomics; 2015 Jul; 16(1):501. PubMed ID: 26148557
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. stat3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
    Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
    Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. stat3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
    Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX
    Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cryptotanshinone inhibits human glioma cell proliferation by suppressing stat3 signaling.
    Lu L; Li C; Li D; Wang Y; Zhou C; Shao W; Peng J; You Y; Zhang X; Shen X
    Mol Cell Biochem; 2013 Sep; 381(1-2):273-82. PubMed ID: 23740516
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inhibition of stat3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
    Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
    Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
    Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
    Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The transcriptional network for mesenchymal transformation of brain tumours.
    Carro MS; Lim WK; Alvarez MJ; Bollo RJ; Zhao X; Snyder EY; Sulman EP; Anne SL; Doetsch F; Colman H; Lasorella A; Aldape K; Califano A; Iavarone A
    Nature; 2010 Jan; 463(7279):318-25. PubMed ID: 20032975
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
    Wang W; Edington HD; Rao UN; Jukic DM; Land SR; Ferrone S; Kirkwood JM
    Clin Cancer Res; 2007 Mar; 13(5):1523-31. PubMed ID: 17332298
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Retinoic acid increases proliferation rate of GL-15 glioma cells, involving activation of STAT-3 transcription factor.
    Paillaud E; Costa S; Fages C; Plassat JL; Rochette-Egly C; Monville C; Tardy M
    J Neurosci Res; 2002 Mar; 67(5):670-9. PubMed ID: 11891779
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.